Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Oct 29, 2016 | $19.6B |
| FY2017, ended Oct 28, 2017 | $33.6B |
| FY2018, ended Nov 3, 2018 | $32.3B |
| FY2019, ended Nov 2, 2019 | $40.3B |
| FY2020, ended Oct 31, 2020 | $43.8B |
| FY2021, ended Oct 30, 2021 | $91.1B |
| FY2022, ended Oct 29, 2022 | $73.8B |
| FY2023, ended Oct 28, 2023 | $79.7B |
| FY2024, ended Nov 2, 2024 | $112B |
| FY2025, ended Nov 1, 2025 | $115B |
| Trailing 12 months to Aug 1, 2026 (through Q3 FY2026) | $178B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Oct 29, 2016 | $3.42B |
| FY2017, ended Oct 28, 2017 | $5.25B |
| FY2018, ended Nov 3, 2018 | $6.22B |
| FY2019, ended Nov 2, 2019 | $5.99B |
| FY2020, ended Oct 31, 2020 | $5.60B |
| FY2021, ended Oct 30, 2021 | $7.32B |
| FY2022, ended Oct 29, 2022 | $12.0B |
| FY2023, ended Oct 28, 2023 | $12.3B |
| FY2024, ended Nov 2, 2024 | $9.43B |
| FY2025, ended Nov 1, 2025 | $11.0B |
| Trailing 12 months to Aug 1, 2026 (through Q3 FY2026) | $13.9B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Oct 29, 2016 | $862M | $1.16B |
| FY2017, ended Oct 28, 2017 | $805M | $950M |
| FY2018, ended Nov 3, 2018 | $1.51B | $2.19B |
| FY2019, ended Nov 2, 2019 | $1.36B | $1.98B |
| FY2020, ended Oct 31, 2020 | $1.22B | $1.84B |
| FY2021, ended Oct 30, 2021 | $1.39B | $2.39B |
| FY2022, ended Oct 29, 2022 | $2.75B | $3.78B |
| FY2023, ended Oct 28, 2023 | $3.31B | $3.56B |
| FY2024, ended Nov 2, 2024 | $1.64B | $3.12B |
| FY2025, ended Nov 1, 2025 | $2.27B | $4.28B |
| Trailing 12 months to Aug 1, 2026 (through Q3 FY2026) | $4.14B | $4.94B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Oct 29, 2016 | $921M |
| FY2017, ended Oct 28, 2017 | $1.05B |
| FY2018, ended Nov 3, 2018 | $817M |
| FY2019, ended Nov 2, 2019 | $648M |
| FY2020, ended Oct 31, 2020 | $1.06B |
| FY2021, ended Oct 30, 2021 | $1.98B |
| FY2022, ended Oct 29, 2022 | $1.47B |
| FY2023, ended Oct 28, 2023 | $958M |
| FY2024, ended Nov 2, 2024 | $1.99B |
| FY2025, ended Nov 1, 2025 | $2.50B |
| Trailing 12 months to Aug 1, 2026 (through Q3 FY2026) | $2.17B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Oct 29, 2016 | $0 |
| FY2017, ended Oct 28, 2017 | $300M |
| FY2018, ended Nov 3, 2018 | $67.0M |
| FY2019, ended Nov 2, 2019 | $300M |
| FY2020, ended Oct 31, 2020 | $0 |
| FY2021, ended Oct 30, 2021 | $6.78B |
| FY2022, ended Oct 29, 2022 | $6.58B |
| FY2023, ended Oct 28, 2023 | $6.95B |
| FY2024, ended Nov 2, 2024 | $7.98B |
| FY2025, ended Nov 1, 2025 | $8.59B |
| Trailing 12 months to Aug 1, 2026 (through Q3 FY2026) | $9.12B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 57.2% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Oct 29, 2016 | 308M |
| FY2017, ended Oct 28, 2017 | 369M |
| FY2018, ended Nov 3, 2018 | 370M |
| FY2019, ended Nov 2, 2019 | 368M |
| FY2020, ended Oct 31, 2020 | 369M |
| FY2021, ended Oct 30, 2021 | 525M |
| FY2022, ended Oct 29, 2022 | 509M |
| FY2023, ended Oct 28, 2023 | 496M |
| FY2024, ended Nov 2, 2024 | 496M |
| FY2025, ended Nov 1, 2025 | 490M |
| Trailing 12 months to Aug 1, 2026 (through Q3 FY2026) | 485M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Oct 29, 2016 | $370M | $63.4M |
| FY2017, ended Oct 28, 2017 | $46.5M | $104M |
| FY2018, ended Nov 3, 2018 | $226M | $151M |
| FY2019, ended Nov 2, 2019 | $613M | $150M |
| FY2020, ended Oct 31, 2020 | $244M | $150M |
| FY2021, ended Oct 30, 2021 | $2.61B | $244M |
| FY2022, ended Oct 29, 2022 | $2.58B | $323M |
| FY2023, ended Oct 28, 2023 | $2.96B | $300M |
| FY2024, ended Nov 2, 2024 | $616M | $263M |
| FY2025, ended Nov 1, 2025 | $2.16B | $322M |
| Trailing 12 months to Aug 1, 2026 (through Q3 FY2026) | $3.13B | $350M |
Valuation
At current price- Market Cap
- $206B
- P/E
- 49.8×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 14.8×
- Price / Book
- 6.1×
- EV / EBITDA
- 30.9×
Growth
Trailing 12 months- Revenue (TTM)
- $13.9B
- Revenue Growth YoY
- 33.6%
- Revenue CAGR 3Y
- −2.8%
- Revenue CAGR 5Y
- 14.5%
- EPS Growth YoY
- 114%
- Net Income Growth YoY
- 111%
Profitability
Trailing 12 months- Gross Margin
- 65.8%
- Operating Margin
- 35.5%
- Net Margin
- 29.8%
- FCF Margin
- 35.6%
- Return on Equity
- 12.2%
Earnings
Trailing 12 months- Net Income
- $4.14B
- EPS (diluted)
- $8.42
- EBITDA
- $6.91B
- Operating Income
- $4.93B
Balance Sheet
As of Aug 1, 2026- Cash and cash equivalents
- $2.17B
- Total Debt
- $9.12B
- Net Debt
- $6.96B
- Total Assets
- $48.4B
- Total Liabilities
- $14.9B
- Shareholders' Equity
- $33.6B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $5.55B
- Capital Expenditure
- $608M
- Free Cash Flow
- $4.94B
Dividends and risk
Last 12 months- Dividend Yield
- 1.0%
- Dividend / Share
- $4.29
- Beta (5Y)
- 1.22
Every ratio is calculated from the company’s reported figures.